Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.85.12.7087PMID 11134132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.

  2000cited by this paper
• Insulin-like growth factor-I and cognitive function in healthy older men.

  1999cited by this paper
• Molecular Analysis of the Growth Hormone Secretagogue Receptor

  1999cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Growth hormone-releasing peptides and their analogs.

  1998cited by this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cited by this paper
• Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.

  1998cited by this paper
• cis-unsaturated free fatty acids block growth hormone and prolactin secretion in thyrotropin-releasing hormone-stimulated GH3 cells by perturbing the function of plasma membrane integral proteins.

  1997cited by this paper
• Association of Insulin‐Like Growth Factor‐I with Body Composition, Weight History, and Past Health Behaviors in the Very Old: The Framingham Heart Study

  1997cited by this paper
• Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.

  1997cited by this paper
• Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

  1996cited by this paper
• Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.

  1996cited by this paper
• Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity.

  1996cited by this paper
• Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.

  1996cited by this paper
• Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.

  1996influential reference
• Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.

  1995cited by this paper
• Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.

  1995cited by this paper
• Growth hormone-releasing activity of hexarelin in humans

  1994cited by this paper
• Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.

  1994cited by this paper
• Effects of growth hormone on lipolysis in humans

  1994cited by this paper
• Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects

  1994cited by this paper
• Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.

  1994cited by this paper
• Human growth hormone and human aging.

  1993cited by this paper
• Stimulatory effect of free fatty acids on growth hormone releasing hormone secretion by fetal rat neurons in monolayer culture.

  1992cited by this paper
• Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat.

  1991cited by this paper
• Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

  1991cited by this paper
• Effects of human growth hormone in men over 60 years old.

  1990cited by this paper
• Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations.

  1987cited by this paper
• Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary.

  1987cited by this paper
• Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.

  1984cited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society cis-Unsaturated Free Fatty Acids Block Growth Hormone and Prolactin Secretion in Thyrotropin- Releasing Hormone-Stimulated GH 3 Cells by Perturbing the Function of Plasma Membrane Integral Protei

  year unknowncited by this paper

• Review of the relationship between growth hormone and SARS-CoV-2 infection

  2025cites this paper
• Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.

  2023cites this paper
• Insight on sarcopenic obesity and epicatechin as a promising treatment option.

  2023cites this paper
• Osteosarcopenia

  2022cites this paper
• Effect of Intake of Leucine-Rich Protein Supplement in Parallel with Resistance Exercise on the Body Composition and Function of Healthy Adults

  2022cites this paper
• SARCOPENIC OBESITY – A CLINICAL REVIEW

  2021cites this paper
• Factor Analysis for Body Mass Index Changes in Kidney Transplant Recipients.

  2021cites this paper
• The Critical Role of Oxidative Stress in Sarcopenic Obesity

  2021cites this paper
• Nutrients for Bone Health

  2019cites this paper
• Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures

  2019influential citation
• Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure.

  2018cites this paper
• Sarcopenic obesity in Scottish older community-dwellers : a weight loss intervention using high protein intake and mixed exercise training to augment body composition and function in older age

  2018cites this paper
• Acyl Ghrelin Induces Insulin Resistance Independently of GH, Cortisol, and Free Fatty Acids

  2017cites this paper
• Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)

  2017influential citation
• Sarcopenic Obesity and the Pathogenesis of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction

  2015cites this paper
• Sarcopenic Obesity and Endocrinal Adaptation with Age

  2013cites this paper
• How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?

  2012cites this paper
• Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men.

  2012cites this paper
• Results of clinical research to improve EVAR

  2011cites this paper
• Caffeine attenuates acute growth hormone response to a single bout of resistance exercise.

  2010cites this paper
• Sarcopenic obesity - definition, etiology and consequences

  2009cites this paper
• Growth hormone secretory in healthy aged women and men of Tunisian population

  2009cites this paper
• Growth Hormone Secretagogues in Perspective

  2009cites this paper
• A influência de um programa de treinamento de força muscular, nas fases neurogênica e miogênica, sobre os níveis de IGF-1 em idosas sedentárias

  2008cites this paper
• Sarcopenic obesity: definition, cause and consequences

  2008cites this paper
• [Trp3, Arg5]-ghrelin(1-5) stimulates growth hormone secretion and food intake via growth hormone secretagogue (GHS) receptor.

  2006cites this paper
• Perfil de secreção de hormônio de crescimento e ghrelina antes e após cirurgia bariátrica

  2005cites this paper
• Prior endurance exercise attenuates growth hormone response to subsequent resistance exercise

  2005cites this paper
• Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.

  2004cites this paper
• Obesity in the elderly: who should we be treating, and why, and how?

  2004cites this paper
• Discovery of Novel Receptors for Lipid Mediators - a study leading to the identification of receptors involved in metabolism and the immune system

  2004cites this paper
• Seric levels of IGF-1 in elderly people

  2003cites this paper
• Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH‐releasing hormone test

  2003influential citation
• Níveis séricos de IGF-1 em gerontes

  2003cites this paper
• Niveles séricos de IGF-1 en gerontes

  2003cites this paper
• Anti-Aging Medicine LiteratureWatch

  2001cites this paper